Ignite Creation Date:
2025-12-24 @ 9:12 PM
Ignite Modification Date:
2025-12-25 @ 7:01 PM
Study NCT ID:
NCT04240704
Status:
TERMINATED
Last Update Posted:
2025-10-10
First Post:
2020-01-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHL
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-05
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-23
First Submit QC Date:
None
Study First Post Date:
2020-01-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-08
Last Update Post Date:
2025-10-10
Last Update Post Date Type:
ESTIMATED